🔗 Visit the ClinicalTrials.gov page for NCT01277406
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents. | Molecules | 2015 | 1.25 |
| 2 | Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies. | Cancers (Basel) | 2013 | 0.89 |
| 3 | Molecular Subtypes and Personalized Therapy in Metastatic Colorectal Cancer. | Curr Colorectal Cancer Rep | 2016 | 0.78 |
| 4 | First-in-human, pharmacokinetic and pharmacodynamic phase I study of Resminostat, an oral histone deacetylase inhibitor, in patients with advanced solid tumors. | Clin Cancer Res | 2013 | 0.78 |